Home > Analytics > BLISS GVS PHARMA

BLISS GVS PHARMA
Intrinsic Value | Fundamental Analysis

BOM : 506197     NSE : BLISSGVS    
LT :  
    Long Term Analysis
Fundamentals : Average
Valuation : Average [Stock is fairly valued]
Debt : Low
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
May 22,2024
Price(EOD): ₹ 109.40
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Pharmaceuticals & Drugs
MCap: ₹ 1,145.42 Cr
Value of ₹ 1 Lac invested in BLISS GVS PHARMA
on May 22,2019 (price: ₹ 167.60)

₹ 1 L

₹ 0.65 L

1W : 0.2% 1M : -5.3% 1Y : 48.9%
COMMUNITY POLL
for BLISS GVS PHARMA
Please provide your vote to see the results
Industry Peers & Returns1W1M1Y
BLISS GVS PHARMA 0.2% -5.3% 48.9%
SUN PHARMACEUTICAL INDUSTRIES 0.3% 0.1% 65.8%
CIPLA 4.3% 9.4% 57.8%
DR REDDYS LABORATORIES 0.6% -2.4% 30.8%
ZYDUS LIFESCIENCES 6.7% 12.2% 114.6%
DIVIS LABORATORIES 3.3% 8.7% 27.3%
MANKIND PHARMA 0.7% -9.9% 53.7%
TORRENT PHARMACEUTICALS -1.3% 3% 62.6%
LUPIN 3% 6.6% 116.1%

FUNDAMENTAL ANALYSIS OF BLISS GVS PHARMA

 
Fundamentals Score
[ Q(TTM): Mar2024, Y: Mar2023
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]


VALUATION OF BLISS GVS PHARMA

 
Valuation Score
[As on : May 22,2024 ]

Ratio Consolidated
P/E
P/B
P/S
14.05
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 81.58 Cr
[Latest Qtr - Mar2024 - Consolidated Results ]

1.31
P/B Calculated based on Book Value of Rs 875.00 Cr
[Latest Year - Mar2023 - Consolidated Results ]

1.49
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 770.24 Cr
[Latest Qtr - Mar2024 - Consolidated Results ]

Financial Ratios →

Insights 💡 There are potential 12% undervalued companies ! Discover More →

FAIR VALUE OF BLISS GVS PHARMA

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
23%
-14%
-16%

Insights 💡 You can learn about various Valuation techniques to calculate Intrinsic Value
with our bestselling video course Value Investing - The Ultimate Guide
Take Me There →

SHARE PRICE MOMENTUM OF BLISS GVS PHARMA



BLISS GVS PHARMA vs SENSEX


Insights 💡 You can learn about Basics of Stock Marketing Investing
with our bestselling video course Stock Marketing Investing Simplified
Take Me There →

DEBT OF BLISS GVS PHARMA

Year Debt/Equity ratio
Standalone Consolidated
2023
2022
2021
Avg_3yrs
0.08
0.1
0.12
0.1
0.11
0.13
0.15
0.13
[Last Annual Data : Mar2023]
Financial Ratios →

PLEDGED PROMOTER SHARES OF BLISS GVS PHARMA

Pledged Promoter Shares
0 %
As on : Dec2023

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad
Shareholding Pattern →

QTRLY RESULTS OF BLISS GVS PHARMA

Consolidated Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
-1.29%
-35.12%
-109.86%
-116.9%
7.22%
354.21%
-427.24%
-241.74%
QtrlyTrend
-4
Latest Qtr: Mar2024
Quarterly Result Analysis →


BLISS GVS PHARMA related INDICES

BSE Indices1W1M1Y
S&P BSE MIDSMALLCAP 3.1% 6.7% 62.1%
S&P BSE SMALL CAP 3.1% 5.6% 60.5%
S&P BSE ALLCAP 2.4% 4.2% 38.5%
S&P BSE HEALTHCARE 1.9% 4.1% 55.2%
No NSE index found

You may also like the below Video Courses


FAQ about BLISS GVS PHARMA


Is BLISS GVS PHARMA good for long term investment?

As on May 22,2024, the Fundamentals of BLISS GVS PHARMA look Average and hence you may wait for the results to improve to invest for long term ! See Financial Performance of BLISS GVS PHARMA . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is BLISS GVS PHARMA UnderValued or OverValued?

As on May 22,2024, BLISS GVS PHARMA is Fairly Valued based on the estimates of intrinsic value and investors may wait for the buying opportunity once it becomes under valued!

What is the Intrinsic Value of BLISS GVS PHARMA ?

As on May 22,2024, the Intrinsic Value of BLISS GVS PHARMA is Rs. 127.91 estimated based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 89.14
Fair Value [Median EV / Sales Model] : Rs. 127.91
Fair Value [Median Price / Sales Model] : Rs. 130.39
Estimated Median Fair Value of BLISS GVS PHARMA : Rs. 127.91

The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.

Is BLISS GVS PHARMA trading at a Premium or Discount?

As on May 22,2024, BLISS GVS PHARMA is trading at a Discount of -14% based on the estimates of Median Intrinsic Value!